- - oalib

OALib Journal期刊
ISSN: 2333-9721
费用：99美元

投递稿件

为什么选择我们？ >>

- 开源期刊

- 同行审议

- 快速出刊

- 终身存储

- 免费检索

- 免费推广

- 更多...

- 搜索引擎

-

ISSN Print: 1474-1768

ISSN Online:

主页: https://www.nature.com/nrc

分享:

Engineering advanced cancer therapies with synthetic biology

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Extrachromosomal oncogene amplification in tumour pathogenesis and evolution

Host tissue determinants of tumour immunity

Diverging inflammasome signals in tumorigenesis and potential targeting

Epigenetic therapy in immune-oncology

Immune control by amino acid catabolism during tumorigenesis and therapy

Rare ribosomopathies: insights into mechanisms of cancer

Tertiary lymphoid structures in the era of cancer immunotherapy

Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion

The broken cycle: E2F dysfunction in cancer

Going to extremes: determinants of extraordinary response and survival in patients with cancer

Targeting cancer vulnerabilities with high-dose vitamin C

Cancer overdiagnosis: a biological challenge and clinical dilemma

Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data

Targeting chromatin complexes in fusion protein-driven malignancies

Stem cell fate in cancer growth, progression and therapy resistance

Rewiring urea cycle metabolism in cancer to support anabolism

Post-GWAS in prostate cancer: from genetic association to biological contribution

Cooperation among cancer cells: applying game theory to cancer

The lung microenvironment: an important regulator of tumour growth and metastasis

Nutrient scavenging in cancer

Polyamine metabolism and cancer: treatments, challenges and opportunities

The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers

Tumour-targeting bacteria engineered to fight cancer

Fasting and cancer: molecular mechanisms and clinical application

A model for RAS mutation patterns in cancers: finding the sweet spot

Cytokinesis defects and cancer

mTOR signalling and cellular metabolism are mutual determinants in cancer

Genomic evolution of cancer models: perils and opportunities

Therapeutically exploiting STAT3 activity in cancer — using tissue repair as a road map

Cell-in-cell phenomena in cancer

Cancer in wildlife: patterns of emergence

©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705